Intelligence Platform

Patents

Browse 406 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6544970

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6545049

Dimer-selective RXR modulators and methods for their use

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6545142

Single domain ligands, receptors comprising said ligands, methods for their production, an

Medical Research Council of the United Kingdom · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521633

Treating NIDDM with RXR agonists

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6521657

Thio-oxindole derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6518480

Selective target cell activation by expression of a G protein-coupled receptor activated s

The Regents of the University of California · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6509334

Cyclocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506796

Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506766

Glucocortiocoid-selective antinflammatory agents

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6506382

Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligan

The Board of Regents of the University of Oklahoma · Granted Tue Jan 14 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498154

Cyclic regimens using quinazolinone and benzoxazine derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6492324

APJ ligand polypeptides

Takeda Chemical Industries Ltd. · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482411

Methods of reducing bone loss with CD40 ligand

The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6479531

Gastrin and cholecystokinin receptor ligands

The James Black Foundation Limited · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462038

Androgen receptor modulator compounds and methods

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6462032

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6451759

Noncleavable Fas ligand

The Regents of the University of California · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6441137

Expressed ligand-vascular intercellular signalling molecule

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6441019

Cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6436929

Cyclothiocarbamate derivatives as progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6433143

Tie-2 ligands

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6432667

Polynucleotide encoding TIE-2 ligand-4

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired